- Home
- C vs ABT Comparison
C vs ABT Comparison
Compare C & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | C | ABT |
|---|---|---|
| Founded | 1812 | 1888 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 193.7B | 189.6B |
| IPO Year | N/A | 2006 |
Fundamental Metrics
Financial Performance| Metric | C | ABT |
|---|---|---|
| Price | $105.63 | $107.91 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 16 |
| Target Price | $124.50 | ★ $139.38 |
| AVG Volume (30 Days) | ★ 11.5M | 6.7M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | 2.27% | ★ 2.33% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 3.72 |
| Revenue | N/A | ★ $44,328,000,000.00 |
| Revenue This Year | $21.84 | $8.92 |
| Revenue Next Year | $3.86 | $7.39 |
| P/E Ratio | ★ $16.63 | $29.02 |
| Revenue Growth | N/A | ★ 5.67 |
| 52 Week Low | $55.51 | $105.27 |
| 52 Week High | $125.16 | $137.49 |
Technical Indicators
Market Signals| Indicator | C | ABT |
|---|---|---|
| Relative Strength Index (RSI) | 38.99 | 35.98 |
| Support Level | $92.68 | $105.27 |
| Resistance Level | $124.06 | $113.76 |
| Average True Range (ATR) | 3.40 | 1.93 |
| MACD | -0.53 | -0.43 |
| Stochastic Oscillator | 22.13 | 2.91 |
Price Performance
Historical ComparisonAbout C Citigroup Inc.
Citigroup is a global financial-services company doing business in more than 160 countries and jurisdictions. Citigroup's operations are organized into five primary segments: services, markets, banking, US personal banking, and wealth management. The bank's primary services include cross-border banking needs for multinational corporates, investment banking and trading, and credit card services in the United States.
About ABT Abbott Laboratories
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.